Publicaciones en colaboración con investigadores/as de Vall d'Hebron Institut de Recerca (18)

2023

  1. Clinical features and factors related to lifetime suicidal ideation and suicide attempts in patients who have had substance-induced psychosis across their lifetime

    Psychiatry Research, Vol. 323

2022

  1. A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment

    Neuropsychiatric Disease and Treatment, Vol. 18, pp. 965-976

  2. Frequency and Associated Factors of Suicidal Ideation in Patients with Chronic Obstructive Pulmonary Disease

    Journal of Clinical Medicine, Vol. 11, Núm. 9

2021

  1. Alexithymia in Patients With Substance Use Disorders and Its Relationship With Psychiatric Comorbidities and Health-Related Quality of Life

    Frontiers in Psychiatry, Vol. 12

  2. Effectiveness of tianeptine in patients with m ajor depression and substance-related disorders

    Actas Espanolas de Psiquiatria, Vol. 49, Núm. 4, pp. 135-144

  3. Is alexithymia related to retention and relapses in patients with substance use disorders?: A one year follow-up study

    Addictive Behaviors, Vol. 113

  4. Psychiatric Comorbidity and Addiction Severity Differences in Patients With ADHD Seeking Treatment for Cannabis or Cocaine Use Disorders

    Journal of Attention Disorders, Vol. 25, Núm. 7, pp. 978-988

  5. Psychosis induced by abuse of ayahuasca: a case report

    Revista Colombiana de Psiquiatria, Vol. 50, Núm. 1, pp. 43-46

  6. Treatment retention and abstinence of patients with substance use disorders according to addiction severity and psychiatry comorbidity: A six-month follow-up study in an outpatient unit

    Addictive Behaviors, Vol. 117

  7. Validation of the Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales in French, Spanish, and German Languages, among a Sample of Opioid Users

    European Addiction Research, Vol. 27, Núm. 5, pp. 326-331

2020

  1. Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review

    Reproductive Health, Vol. 17, Núm. 1

  2. Insomnia Symptoms in Patients With Substance Use Disorders During Detoxification and Associated Clinical Features

    Frontiers in Psychiatry, Vol. 11

2017

  1. Peripheral levels of BDNF and opiate-use disorder: Literature review and update

    Reviews in the Neurosciences, Vol. 28, Núm. 5, pp. 499-508

2015

  1. Changes in brain-derived neurotrophic factor (BDNF) during abstinence could be associated with relapse in cocaine-dependent patients

    Psychiatry Research, Vol. 225, Núm. 3, pp. 309-314

2013

  1. Association study of 37 genes related to serotonin and dopamine neurotransmission and neurotrophic factors in cocaine dependence

    Genes, Brain and Behavior, Vol. 12, Núm. 1, pp. 39-46

  2. Brain-derived neurotrophic factor serum levels in cocaine-dependent patients during early abstinence

    European Neuropsychopharmacology, Vol. 23, Núm. 9, pp. 1078-1084

  3. Evaluation of single nucleotide polymorphisms in the miR-183-96-182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs)

    European Neuropsychopharmacology, Vol. 23, Núm. 11, pp. 1463-1473

  4. Serum brain-derived neurotrophic factor levels and cocaine-induced transient psychotic symptoms

    Neuropsychobiology, Vol. 68, Núm. 3, pp. 146-155